Leaked: Last EASY Wealth Opportunity in 2026
Summary
In this video, Felix outlines a strategic approach to growth investing using three specific filters: evaluating a company's cash runway to avoid share dilution, identifying institutional tailwinds like government spending, and spotting revenue inflection points where growth begins to accelerate. He emphasizes that finding the right stock is only half the battle, and that entry points, exit strategies, and risk management are what ultimately separate successful investors from the masses.
Felix provides a deep dive into six specific stocks he believes are undervalued or overlooked by Wall Street:
Mentioned Stocks
Reasoning: Felix highlights the strong institutional tailwind from the CHIPS Act ($100 million intent) and the fact that the US government views quantum computing as a national security priority. Technically, he notes the stock is starting to break out of a long-term 'heartbeat' pattern.
Reasoning: Felix argues Oracle is the backbone of AI infrastructure. With a massive $500 billion backlog and heavy investment in data centers, the company is essential for the operation of major AI firms like OpenAI and Anthropic.
Reasoning: Felix views this as a high-potential bet on the future of electric aviation. Despite being pre-revenue, the company has $3.9 billion in orders from major players like UPS and United Therapeutics, and it holds nearly all the FAA's fast-track certification slots.
Reasoning: Felix identifies Dynatrace as a necessary utility for the AI era, providing automated monitoring and fixing of AI systems. He points to their $1 billion buyback and healthy margins as indicators of a strong, stable growth play.
Reasoning: Felix explicitly stated he bought this stock recently. He believes cybersecurity is a non-discretionary budget item for companies deploying AI. He notes the stock is currently underpriced relative to its potential and shows signs of institutional accumulation following a deep sell-off.
Reasoning: This is Felix's favorite stock because of its massive upside as a turnaround story. He highlights their leadership in spatial biology and new AI partnerships that could revolutionize medical diagnostics. It is currently trading at an 85% discount from its all-time high.